Influence of preoperative core biopsies on uPA/PAI-1 expression in breast cancer tissue

Virchows Archiv

Volumn 452, Issue 3, 2008, Pages 277-283

  Haas, Susanne ^a   Park, Tjoung Won ^b   Hahne, Jens Claus ^a   Fischer, Hans Peter ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Breast cancer; Inflammation; PAI 1; Preoperative sampling; uPA

Indexed keywords

PARAFFIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER CELL; CANCER TISSUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAJOR CLINICAL STUDY; NEEDLE BIOPSY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUNCH BIOPSY; BIOPSY; BIOSYNTHESIS; BREAST; BREAST TUMOR; CHEMISTRY; FEMALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PREOPERATIVE CARE; STANDARD; TIME;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST; BREAST NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREOPERATIVE CARE; TIME FACTORS; URINARY PLASMINOGEN ACTIVATOR;

EID: 48149107201     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-007-0563-8     Document Type: Article

References (19)

1. PA Andreasen R Egelund HH Petersen 2000 The plasminogen activation system in tumor growth, invasion, and metastasis Cell Mol Life Sci 57 1 25 40
2. PA Andreasen L Kjoller L Christensen MJ Duffy 1997 The urokinase-type plasminogen activator in cancer metastasis: a review Int J Cancer 72 1 22
3. JL Camps SM Chang TC Hsu MR Freeman SJ Hong HE Zhau AC von Eschenbach LW Chung 1990 Fibroblast mediated acceleration of human epithelial tumor growth in vivo Proc Natl Acad Sci USA 87 75 79
4. E Dublin A Hanby NK Patel R Liebman D Barnes 2000 Immunohistochemical expression of uPA, uPAR, and PAI-1 in breast carcinoma Am J Pathol 157 1219 1227
5. MJ Duffy D Reilly C O'Sullivan N O'Higgins JJ Fennelly P Andreasen 1990 Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer Cancer Res 50 6827 6829
6. CM Ferrier HH de Witte H Straatman DH van Tienoven WL van Geloof FJR Rietveld CGJ Sweep DJ Ruiteer GNP van Muijen 1999 Comparison of immunohistochemistry with immunoassay (ELISA) for the detection of components of the plasminogen activation system in human tumour tissue Br J Cancer 79 1534 1541
7. S Ganesh CF Sier G Griffioen HJ Vloedgraven A de Boer K Welvaart CJ de Velde JH van Krieken JH Verheijen CB Lamers 1994 Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer Cancer Res 54 4065 4071
8. N Harbeck RE Kates MP Look ME Meijer-van Gelder JGM Klijn F Jänicke A Krüger M Kiechle M Schmitt JA Foekens 2002 Enhanced benefit from adjuvant systemic chemotherapy in breast cancer patients classified high risk according to uPA and PAI-1 (n=3424) Cancer Res 62 4617 4622
9. F Jänicke A Prechtl C Thomssen N Harbeck C Meisner M Untch CG Sweep HK Selbmann H Graeff M Schmitt for the German Chemo N0 Study group 2001 Randomized adjuvant chemotherapy trial in high-risk lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type I J Natl Cancer Inst 93 913 920
10. AHS Lee CE Gillett K Ryder IS Fentiman DW Miles RR Millis 2006 Different patterns of inflammation and prognosis in invasive carcinoma of the breast Histopathology 48 692 701
11. LA Liotta EC Kohn 2001 The microenvironment of the tumour-host interface Nature 411 375 379
12. MP Look WLJ van Putten MJ Duffy N Harbeck IJ Christensen C Thomssen R Kates F Spyratos M Fernö S Eppenberger-Castori CGJ Sweep K Ulm JP Peyrat PM Martin H Magdelenat N Brünner C Duggan BW Lisboa PO Bendahl V Quillien A Daver G Ricolleau ME Meijer-van Gelder P Mander E fiets MA Blankenstein P Broet S Romain G Daxenbichler G Windbichler T Cufer S Borstnar W Kueng LVAM Beex JGM Klijn NO O'Higgins U Eppenberger F Jänicke M Schmitt JA Foekens 2002 Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients J Natl Cancer Institute 94 116 128
13. BS Nielsen M Sehested S Suun F Rank S Timshel J Rygaard M Johnsen K Dano 2001 Urokinase plasminogen activator is localized in stromal cells in ductal breast cancer Lab Invest 81 1485 1501
14. AF Olumi P Dazin TD Tlsty 1998 A novel coculture technique demonstrates that normal human prostatic fibroblasts contribute to tumor formation of LNCaP cells by retarding cell death Cancer Res 58 4525 4530
15. H Pappot H Gardsvoll J Romer AN Pedersen J Grondahl-Hansen C Pyke N Brunner 1995 Plasminogen activator inhibitor type 1 in cancer: therapeutic and prognostic implications Biol Chem Hoppe Seyler 376 5 259 267
16. C Pyke E Ralfkiaer K Tryggvason K Dano 1993 Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer Am J Pathol 142 359 365
17. BM Schäfer K Maier U Eickhoff RF Todd MD Kramer 1994 Plasminogen activation in healing human wounds Am J Pathology 144 1269 1280
18. M Schmitt F Janicke N Moniwa N Chucholowski L Pache H Graeff 1992 Tumor-associated urokinase-type plasminogen activator: biological and clinical significance Biol Chem Hoppe Seyler 373 7 611 22
19. CGJ Sweep J Geurts-Moespot N Grebenschikov JH de Witte JJTM Heuvel M Schmitt MJ Duffy F Jänicke MD Kramer JA Foekens N Brünner G Brugal AN Pedersen TJ Benraad 1998 External quality assessment of trans-European multicentre antigen determinations (ELISA) of urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PI-1) in human breast cancer tissue extracts Br J Cancer 78 1434 1441